Episode Details
Back to EpisodesMcDonald's Bets $8B on Ozempic Era, Red Bull vs. Kroger
Published 1 week ago
Description
McDonald's just spent $8 billion signalling that GLP-1 drugs have permanently changed food strategy. If the world's biggest QSR is reformulating, supplement and functional food brands need to act now.
In this episode:
- McDonald's announced an $8B+ menu and strategy overhaul explicitly framed around GLP-1 drug adoption, signalling that nutrient-dense, smaller-format products are now a structural market requirement for all food and supplement brands.
- New research published in Science Daily found that a topical senolytic compound cleared senescent 'zombie' cells in older mice, significantly accelerating skin wound healing and raising the scientific bar for ingredient claims in longevity skincare.
- Kroger is drawing a hard line on pricing with Red Bull — one of the world's most dominant beverage brands — exposing a structural shift in retailer-brand power dynamics that European functional drink and supplement brands entering retail must plan for from day one.
- SunOpta is expanding plant-based manufacturing capacity while Maple Leaf simultaneously retreats from the category, creating both supply chain opportunities and risks for wellness and functional food brands relying on plant-based ingredient suppliers through 2026 and beyond.
The Health Marketing Daily is a concise briefing for marketers and founders in supplements, functional food and consumer health, hosted by Marco & Klara. New episode every day.
Enjoying the show? A quick rating or review on Apple Podcasts or Spotify helps other marketers find us.
Also from Marco & Klara: The FMCG Marketing Daily · The Digital Commerce Daily